Literature DB >> 32487632

Spleen Volume as a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.

Takashi Miyata1, Hiroyuki Takamura2, Ryosuke Kin1, Hisashi Nishiki1, Akifumi Hashimoto1, Yoritaka Fujii1, Seiko Miura1, Jun Fujita1, Daisuke Kaida1, Yasuto Tomita1, Naohiko Nakamura1, Hideto Fujita1, Shinichi Kinami1, Nobuhiko Ueda1, Takeo Kosaka1.   

Abstract

BACKGROUND/AIM: We evaluated whether splenic volume (SV) predicts sinusoidal obstruction syndrome (SOS) in colorectal cancer (CRC) patients receiving capecitabine plus oxaliplatin (CapeOX) therapy. PATIENTS AND METHODS: In this retrospective study, we measured SV in 41 patients receiving adjuvant CapeOX for CRC at five different time points. We compared the clinical data of the 18 patients who experienced ≥30% increases in SV immediately after vs. before CapeOX (group A) with data for the remaining 23 patients (group B).
RESULTS: Platelet numbers decreased and the levels of hepatobiliary enzymes increased significantly 1 year after CapeOX compared with before CapeOX in group A. However, in group B, significantly decreased platelet numbers and significantly increased aspartate transaminase levels were confirmed only immediately after CapeOX, with no significant subsequent changes.
CONCLUSION: SV was significantly associated with thrombocytopenia and liver dysfunction in CRC patients, and predicted SOS. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Spleen volume; oxaliplatin; sinusoidal obstruction syndrome

Year:  2020        PMID: 32487632     DOI: 10.21873/anticanres.14319

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Hyaluronic Acid May Be a Predictive Biomarker for Thrombocytopenia and Liver Dysfunction After Oxaliplatin-based Chemotherapy.

Authors:  Takashi Miyata; Yasuto Tomita; Yuta San-Nomiya; Taigo Nagayama; Ryosuke Kin; Hisashi Nishiki; Akifumi Hashimoto; Yoritaka Fujii; Seiko Miura; Daisuke Kaida; Naohiko Nakamura; Tomoharu Miyashita; Hideto Fujita; Nobuhiko Ueda; Hiroyuki Takamura
Journal:  Cancer Diagn Progn       Date:  2022-01-03

2.  Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial.

Authors:  Jiren Yu; Yuan Gao; Li Chen; Dan Wu; Qianyun Shen; Zhicheng Zhao; Weihuai Liu; Hanliang Yang; Qi Zhang; Xinbao Wang; Ping Hu; Zhiqiang Zheng; Xianfa Wang; Hongjun Liu; Zekuan Xu; Zhilong Yan; Yingjie Wu; Mingjuan Jin; Qing Zhang; Xiaosun Liu; Kankai Zhu; Chunhui Shou
Journal:  JAMA Netw Open       Date:  2022-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.